We were tasked with developing the campaign’s visual identity, messaging framework, and suite of creative assets. The campaign needed to bring clarity to the “SEE More, PREP Smarter, TREAT Better” proposition, supported by visuals that were not only bold and distinctive, but also clinically accurate.
Boston Scientific wanted to build awareness for its new Modern Endovascular Interventions division and showcase its innovative solutions for the treatment of Peripheral Arterial Disease (PAD). The challenge was to take an approved concept and transform it into a fully realised campaign: one that positioned Boston Scientific as a leader in this field, while making a bold impact at congress and across digital channels.
Working closely with Boston Scientific’s internal stakeholders, we carried out research to ensure every creative decision was grounded in scientific insight and aligned with their strategic goals.
- Visual Identity: We designed the hero image and sub-visuals using bespoke 3D renders of a patient’s leg, arteries, and veins — combining clinical precision with bold, neon-infused design to create a campaign that was both scientifically credible and visually striking.
- Messaging Framework: We created content for each stage of the “SEE, PREP, TREAT” journey, aligning messages to the specific devices and benefits within the portfolio.
- Event & Digital Assets: From booth graphics and animations to congress materials and digital assets, we delivered a cohesive identity that stood out across every touchpoint.
The campaign successfully elevated Boston Scientific’s positioning in Modern Endovascular Interventions, driving awareness of its latest innovations and supporting HCPs in understanding the clinical and procedural benefits of its offering.
This project reflects our role as a trusted healthcare communications agency: turning complex concepts into insight-driven, clinically accurate creative campaigns. It also strengthened our long-term partnership with Boston Scientific, paving the way for future product and pioneering treatment launches.
